BIORQ — Biora Therapeutics Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro CapValue Trap

Annual balance sheet for Biora Therapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2019 December 31st	C2020 December 31st	C2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	—	—	—	—	—
Source:	PROSPECTUS	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	33	92.1	88.4	30.5	15.2
Net Total Accounts Receivable
Net Total Receivables	22.8	6.63	0.653	0.828	0.83
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	74.6	126	98.8	38.1	19.1
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	15.9	8.11	3.67	3.14	2.77
Net Goodwill
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	102	154	109	53.5	31.2
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	100	72.7	61.6	23.3	63
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	186	261	194	156	133
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Total Equity	-83.9	-107	-85	-102	-101
Total Liabilities & Shareholders' Equity	102	154	109	53.5	31.2
Total Common Shares Outstanding